ImmVue Therapeutics Inc. — Form D/A
ImmVue Therapeutics Inc. of TORONTO, A6, a company, filed a Form D amendment with the SEC on 2024-04-18. The offering totals $529K, of which $529K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-04-18
- Form: D/A
- Accession: 0000899797-24-000004
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $529K
- Amount sold: $529K
- Minimum investment: $50K
- Investors: 3
- Date of first sale: 2024-01-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-508035
Issuer
- Name: ImmVue Therapeutics Inc.
- CIK: 0002009514
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 252 RUSSELL HILL RD, TORONTO, A6, M4V 2T2
- Phone: 416-834-5537
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Sandy Der | Director | Toronto, A6 |
| Joon-Hyung John Kim | Director | Toronto, A6 |
| David Moon | Director | Toronto, A6 |
| Jayan John Nagendran | Director | Toronto, A6 |
| Sandy Der | Executive Officer | Toronto, A6 |
| David Moon | Executive Officer | Toronto, A6 |
Other filings by this issuer (1)
More